4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Tecan Group AG (TECN) operates in the Medical Instruments & Supplies industry and is headquartered in Männedorf, Switzerland with about 3,000 employees. Its market capitalization is roughly CHF 2 billion. In the fiscal year ended 2025-12-31, TECN reported CHF 882M in revenue and (CHF 111M) in net income.
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CHF 882M | CHF 934M | CHF 1.1B | CHF 1.1B | — |
| Gross Profit | CHF 311M | CHF 321M | CHF 390M | CHF 438M | — |
| Operating Income (EBIT) | CHF 48M | CHF 76M | CHF 136M | CHF 148M | — |
| Net Income | (CHF 111M) | CHF 68M | CHF 132M | CHF 121M | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CHF 38M) | (CHF 38M) | (CHF 37M) | (CHF 36M) | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CHF 1.7B | CHF 2.1B | CHF 2.1B | CHF 2.1B | — |
| Total Liabilities | CHF 547M | CHF 686M | CHF 725M | CHF 758M | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TECN viewer.
About TickerBase · Data methodology & sources · Privacy · Terms